ArticleResearch square2023

Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe.

Hari K Rachamala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.